Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomes
(MedPage Today) -- Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA.
In the CRYOSTAT-2 trial, adding early, high-dose cryoprecipitate...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news